MORGAN STANLEY - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$78,000
+680.0%
60,492
+540.0%
0.00%
Q3 2019$10,000
-97.8%
9,452
-96.4%
0.00%
Q2 2019$445,000
-54.4%
262,016
-9.4%
0.00%
Q1 2019$975,000
-3.7%
289,343
-16.5%
0.00%
Q4 2018$1,012,000
-53.4%
346,651
-1.8%
0.00%
-100.0%
Q3 2018$2,174,000
-22.2%
352,848
-6.8%
0.00%0.0%
Q2 2018$2,793,000
+17.5%
378,417
+4.5%
0.00%0.0%
Q1 2018$2,377,000
+11.6%
362,167
+43.1%
0.00%0.0%
Q4 2017$2,129,000
-50.3%
253,078
-31.7%
0.00%0.0%
Q3 2017$4,281,000
+47.0%
370,667
+48.7%
0.00%0.0%
Q2 2017$2,912,000
-68.5%
249,299
-66.7%
0.00%0.0%
Q1 2017$9,246,000
-21.1%
749,230
-13.0%
0.00%
-50.0%
Q4 2016$11,726,000
+33.5%
860,946
+95.0%
0.00%
-33.3%
Q3 2016$8,786,000
+64.4%
441,501
+7.1%
0.00%
+50.0%
Q2 2016$5,344,000
+38.2%
412,340
-0.3%
0.00%
+100.0%
Q1 2016$3,867,000
-55.3%
413,672
-3.1%
0.00%
-66.7%
Q4 2015$8,653,000
+69.0%
426,861
+21.1%
0.00%
+50.0%
Q3 2015$5,120,000
+525.9%
352,407
+816.3%
0.00%
Q2 2015$818,000
+5.3%
38,459
+14.7%
0.00%
Q1 2015$777,000
-77.6%
33,539
-77.7%
0.00%
-100.0%
Q4 2014$3,463,000150,2740.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders